| Phase I/II Study of PLB1004 Combined With Platinum-based Doublet Chemotherapy in Patients With EGFR Mutation-positive (NCT07063329) | Avistone Pharmaceutical（Ningbo）Co., LTD. | 2025-08-08 |
| The RECAP2 Study: Midazolam and Psilocybin (NCT06692192) | University of Wisconsin, Madison | 2025-08-07 |
| A Study of AK146D1 for Injection in Advanced Solid Tumors (NCT07067567) | Akeso | 2025-08-07 |
| Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma (NCT06896916) | AbbVie | 2025-08-07 |
| A Study to Learn How the Study Medicine Called Etrasimod is Taken up Into Blood and Breastmilk of Healthy Breastfeeding Women (NCT07153159) | Pfizer | 2025-08-07 |
| Safety Follow-up Study of Participants Dosed With INV-347 in Study INV-CL-108 (NCT07153172) | Novo Nordisk A/S | 2025-08-06 |
| ABL103 in Combination With Pembrolizumab, With or Without Taxane in Advanced or Metastatic Solid Tumors (NCT07158918) | ABL Bio, Inc. | 2025-08-06 |
| Safety, Tolerability and Pharmacokinetic Study of HRS-8829 (NCT07083362) | Beijing Suncadia Pharmaceuticals Co., Ltd | 2025-08-06 |
| A Study to Evaluate the Safety and Immunogenicity of the V3-region Directed Immunogens DV700P-RNA Followed by DV701B1.1-RNA in Adults Without HIV (NCT06919016) | National Institute of Allergy and Infectious Diseases (NIAID) | 2025-08-06 |
| A Phase I/II Trial to Preserve Residual Insulin Secretion in Children With Recent Onset Type 1 Diabetes by Giving Verapamil (NCT07199946) | Johnny Ludvigsson | 2025-08-06 |
| A Study to Test How BI 1584862 is Taken up in the Blood of People With and Without Liver Problems (NCT06957756) | Boehringer Ingelheim | 2025-08-06 |
| A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors. (NCT07021898) | Erasca, Inc. | 2025-08-06 |
| A Multiple Ascending Dose Study With AGMB-129 in Healthy Participants (NCT07118878) | Agomab Spain S.L.U. | 2025-08-06 |
| A Study of LY4257496 in Participants With Cancer (OMNIRAY) (NCT07114601) | Eli Lilly and Company | 2025-08-06 |
| A Study of HDM2012 in Patients With Advanced Solid Tumor (NCT07100249) | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 2025-08-06 |
| Pharmacokinetic/Pharmacodynamic Study of Vicagrel Capsules and Clopidogrel Tablets in Healthy CYP2C19 Normal Metabolizers (NCT07067775) | Jiangsu vcare pharmaceutical technology co., LTD | 2025-08-05 |
| PH Sensitive MRI Based Resections of Glioblastoma (NCT06176066) | University of California, Los Angeles | 2025-08-05 |
| A Pharmacodynamic Study of TS-172 in Healthy Adult Male Subjects (NCT07084961) | Taisho Pharmaceutical Co., Ltd. | 2025-08-05 |
| A Study to Learn About the Study Medicine Called PF-07258669 in Older Adults Including Those at Risk of Malnutrition (NCT07086664) | Pfizer | 2025-08-05 |
| Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver Disease (NCT06825559) | Zydus Therapeutics Inc. | 2025-08-05 |
| A Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis (NCT07100119) | Eli Lilly and Company | 2025-08-05 |
| To Evaluate the Efficacy and Safety of KN060 in Essential Hypertension (NCT07191899) | Suzhou Alphamab Co., Ltd. | 2025-08-05 |
| AB821 in Adult Participants With Locally Advanced or Metastatic Solid Tumors (NCT07027488) | Yale University | 2025-08-05 |
| The Safety, Feasibility, and Repeatability of Inhaled ATP Cough Challenges (NCT07085975) | McMaster University | 2025-08-05 |
| Bioequivalence Study to Compare Empagliflozin / Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjardy XR Tablets 25mg/1000mg (NCT07266766) | Humanis Saglık Anonim Sirketi | 2025-08-05 |
| A Study to Evaluate the Effect of Maridebart Cafraglutide on Insulin Sensitivity and β-cell Function in Participants With Type 2 Diabetes Mellitus (NCT07160257) | Amgen | 2025-08-05 |
| Study of EN-374 Gene Therapy in Participants With X-Linked Chronic Granulomatous Disease (NCT06876363) | Ensoma | 2025-08-05 |
| The Safety and Tolerability of XS411CN Injection in Treatment of Primary Parkinson's Disease (NCT07080775) | XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. | 2025-08-05 |
| Obe-cel in Refractory Progressive Forms of Multiple Sclerosis (NCT07139743) | Autolus Limited | 2025-08-04 |
| A Study of Safety, Tolerability and Preliminary Efficacy of NTS071 in Subjects With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (NCT07060989) | Nutshell Therapeutics (Shanghai) Co., LTD. | 2025-08-04 |
| Testing the Addition of an Investigational Anti-Cancer Drug, ASTX660 (Tolinapant), to a Usual Chemotherapy Treatment (Eribulin) for Treatment of Advanced Triple Negative Breast Cancer (NCT06590558) | National Cancer Institute (NCI) | 2025-08-04 |
| Safety, Tolerability, PK and PD of SSS55 in Healthy Subjects (NCT07058779) | Shenyang Sunshine Pharmaceutical Co., LTD. | 2025-08-04 |
| A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases (NCT07104721) | China Immunotech (Beijing) Biotechnology Co., Ltd. | 2025-08-04 |
| The Potential Therapeutic Effects of Psychedelic, N, N-dimethyltryptamine (DMT), on Alcohol Use Disorder (AUD) (NCT06070649) | Yale University | 2025-08-04 |
| First-in-Human Trial of Oral AN2-502998 (NCT07024589) | AN2 Therapeutics, Inc | 2025-08-04 |
| A Study Evaluating OBI-902 in Participants With Advanced Solid Tumors (NCT07124117) | OBI Pharma, Inc | 2025-08-04 |
| Safety and Efficacy of ZVS203e in the Treatment of Retinitis Pigmentosa Caused by RHO Gene Mutation (NCT06952842) | Chigenovo Co., Ltd | 2025-08-04 |
| A Study Comparing Tretinoin Gel Microsphere, 0.04% and RETIN-A MICRO ® Gel Microsphere, 0.04% in the Treatment of Acne Vulgaris (NCT07469228) | Sun Pharmaceutical Industries, Inc. | 2025-08-04 |
| A Study to Test How BI 1819479 is Taken up and Processed by the Body (NCT07065617) | Boehringer Ingelheim | 2025-08-04 |
| Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa (NCT06834035) | M. Peter Marinkovich | 2025-08-04 |
| Comparative Clinical Trial of Pharmacokinetics and Pharmacodynamics of Human Insulin Injection (NCT07608692) | Zhuhai United Laboratories Co., Ltd. | 2025-08-04 |
| Role of Glucagon-like Peptide-1 Receptor Agonists in Menstrual Irregularities in Adolescent Females With Type 1 Diabetes Mellitus (NCT07319286) | Ain Shams University | 2025-08-04 |
| MDN-001 Injection for the Treatment of Unresectable Primary Hepatocellular Carcinoma. (NCT07391839) | Suzhou Mednovo Yi Medical Technology Co., Ltd. | 2025-08-04 |
| The Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) Trial (NCT06871111) | University of Chicago | 2025-08-04 |
| 64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer (NCT06298916) | Lantheus Medical Imaging | 2025-08-01 |
| Inhaled Treatment for Bronchopulmonary Dysplasia (NCT04619602) | University Hospitals Cleveland Medical Center | 2025-08-01 |
| Evaluation of ICP-B794 in Patients With Advanced Solid Tumors (NCT07136558) | Beijing InnoCare Pharma Tech Co., Ltd. | 2025-08-01 |
| OM336 in Autoimmune Cytopenias (NCT07083960) | Lakefront Biotherapeutics West LLC | 2025-08-01 |
| Oral Changes With Caloric and no Caloric Sweeteners (NCT05852145) | Hospital Infantil de Mexico Federico Gomez | 2025-08-01 |
| A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults: Fed State Study (NCT07044765) | AJU Pharm Co., Ltd. | 2025-08-01 |
| RN1201 Injection in Newly Diagnosed High-Risk Cytogenetic Multiple Myeloma (NCT07114432) | Tianjin Medical University Cancer Institute and Hospital | 2025-08-01 |
| A Clinical Trial in Adults With Non-Hodgkin Lymphoma (NHL), With a Particular Emphasis on Cutaneous T Cell Lymphoma (CTCL), Testing the Safety and Activity of a Novel Drug to Inhibit a Protein Called Tumor Necrosis Factor Receptor 2 That Drives Both Lymphoma Growth and Escape of the Immune System (NCT06385522) | Boston Immune Technologies and Therapeutics | 2025-08-01 |
| Study of TYK-00540 Combined With Enzalutamide in Patients With Metastatic Castration-resistant Prostate Cancer（mCRPC） (NCT07104643) | TYK Medicines, Inc | 2025-08-01 |
| R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors (NCT06398418) | Rise Therapeutics LLC | 2025-08-01 |
| Definitive Proton Radiotherapy Combined With Chemotherapy and Immunotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase I Clinical Study (NCT07034118) | Anhui Provincial Hospital | 2025-08-01 |
| A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults (NCT07034781) | AJU Pharm Co., Ltd. | 2025-08-01 |
| RN1201injection for Relapsed/Refractory CD19+/BCMA+ Hematologic Malignancies (NCT07113496) | The First Affiliated Hospital with Nanjing Medical University | 2025-08-01 |
| A Study to Evaluate the Safety and Pharmacokinetics of AG2304 Compared to Coadministration of AG23041 and AG23042 (NCT06916169) | Ahn-Gook Pharmaceuticals Co.,Ltd | 2025-08-01 |
| Magnetic Resonance-Guided Focused Ultrasound Bilateral Capsulotomy for Refractory Anorexia Nervosa With Comorbid Obsessive Compulsive Disorder or Major Depressive Disorder (NCT07113665) | Sunnybrook Health Sciences Centre | 2025-08-01 |
| Investigating Idetrexed and Olaparib in Patients With Ovarian Cancer (NCT06976892) | Institute of Cancer Research, United Kingdom | 2025-08-01 |
| Safety and Efficacy of AAV9/AP4B1 (BFB-101) For Patients With AP4B1-related Hereditary Spastic Paraplegia Type 47 (SPG47) (NCT06948019) | BlackfinBio Ltd | 2025-08-01 |
| A Clinical Study of BT02 in Treating Patients With Advanced Lung Cancer (NCT07110363) | Biotroy Therapeutics | 2025-08-01 |
| A Study of KC1086 in Patients With Advanced Solid Tumors (NCT07118709) | Beijing Konruns Pharmaceutical Co., Ltd. | 2025-08-01 |
| Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers (NCT07118176) | Jonsson Comprehensive Cancer Center | 2025-08-01 |
| Efficacy Study of Digoxin Combined With Serplulimab and Chemotherapy in First-Line Treatment of MSS Advanced Colorectal Cancer (NCT07025850) | Fudan University | 2025-08-01 |
| A Research Study on How a Dose of NNC0662-0419 Works in Japanese, Chinese and Non-Asian Participants Living With Overweight or Obesity (NCT07101783) | Novo Nordisk A/S | 2025-08-01 |
| Exploring a Natural Solution for Childhood Obesity (NCT07033767) | Western University | 2025-08-01 |
| Towards Efficient Personalization of Computerized Lower Limb Prostheses Via Reinforcement Learning in a Clinical Setup - Group 1 (NCT07204925) | North Carolina State University | 2025-08-01 |
| RN1201 Injection for Autoimmune Diseases Refractory to Standard Therapies (NCT07105735) | The First Affiliated Hospital with Nanjing Medical University | 2025-08-01 |
| Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine (NCT07185815) | Mapi Pharma Ltd. | 2025-08-01 |
| A Tumor Immune Biomarker Guided Approach for Improving Response to BCG in Patients With High-risk NMIBC. (NCT07064863) | Queen's University | 2025-08-01 |
| A Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors (NCT07136142) | Jiangsu HengRui Medicine Co., Ltd. | 2025-08-01 |
| Safety and Immunogenicity of SUM-101 Malaria Vaccine in Children and Infants Living in Burkina Faso (NCT06618885) | European Vaccine Initiative | 2025-08-01 |
| Oxaloacetate in Myasthenia Gravis (NCT04965987) | University of Kansas Medical Center | 2025-08-01 |
| Autologous Neoantigen-Specific T-Cell Therapy for Advanced Hepatocellular Carcinoma (NCT07123545) | Zhejiang University | 2025-08-01 |
| Personalized Vaccine for TNBC Immunotherapy (NCT06195618) | Universidad Nacional de Colombia | 2025-08-01 |
| Combination CAR-T Cell Therapy Targeting Hematological Malignancies (NCT03125577) | Shenzhen Geno-Immune Medical Institute | 2025-08-01 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VT7208 in Healthy Participants and MS Patients (NCT07085507) | Vidya Therapeutics Inc | 2025-08-01 |
| Phase 1b/2a Clinical Trial to Determine the Safety, Tolerability and Efficacy of TZ-161 in Spinal Cord Injury (NCT06677229) | Technophage, SA | 2025-08-01 |
| JDB153 Combined With Penpulimab for Hepatocellular Carcinoma After Standard Treatment Failure (NCT07075419) | West China Hospital | 2025-08-01 |
| A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors (NCT06997029) | Bristol-Myers Squibb | 2025-08-01 |
| Treating Nectin-4-positive Advanced Solid Tumors With R-Star001 (Nectin-4-CART-IL18) (NCT07101549) | changjianhua | 2025-08-01 |
| Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate Cancer (NCT07182279) | The Methodist Hospital Research Institute | 2025-08-01 |
| Study of Intramyocardial Injection of Ventrix Bio Extracellular Matrix (VentriGel) to Assess the Safety and Feasibility in Pediatric Patients with Hypoplastic Left Heart Syndrome (HLHS) (NCT06461676) | Emory University | 2025-08-01 |
| Autologous Adipose Cells Therapy (NCT06869252) | CERM INC. | 2025-08-01 |
| Assessment of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Subcutaneous Injections of GenSci120 in Healthy Adult Participants in China. (NCT07040930) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2025-08-01 |
| The Relationship Between NLR and PONV and ESPB (NCT06127966) | Qianfoshan Hospital | 2025-08-01 |
| Safety and Feasibility of Bilateral Striatal Transplantation of DopaCell in Parkinson's Disease (NCT07572071) | Royan Institute | 2025-08-01 |
| Oncolytic Virus in Esophageal Squamous Cell Carcinoma (NCT07061704) | Sichuan University | 2025-08-01 |
| Study of TY-302 Capsules Combined With Abiraterone in Patients With Metastatic Castration-resistant Prostate Cancer（mCRPC） (NCT07104617) | TYK Medicines, Inc | 2025-08-01 |
| A Clinical Trial Evaluating TQB2101 in Subjects With Advanced Hematologic Malignancies (NCT07113925) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2025-08-01 |
| Application of mRNA Vaccine in Liver Transplantation for Hepatocellular Carcinoma (NCT07077356) | West China Hospital | 2025-08-01 |
| Multiple CAR-T Cell Therapy Targeting AML (NCT04010877) | Shenzhen Geno-Immune Medical Institute | 2025-08-01 |
| Safety and Efficacy of Radiotherapy Combined with Immunotherapy for Advanced Malignant Tumors. (NCT06173219) | China-Japan Friendship Hospital | 2025-08-01 |
| Local Immunomodulation After Radiofrequency of Unresectable Colorectal Liver Metastases (NCT04062721) | Assistance Publique - Hôpitaux de Paris | 2025-08-01 |
| In-Season Prevalence and Management of Hip and Groin Injuries in Competitive Athletes (NCT07108647) | University of Calgary | 2025-08-01 |
| Intervention of Bladder Cancer by CAR-T (NCT03185468) | Shenzhen Geno-Immune Medical Institute | 2025-08-01 |
| The Impact of Remimazolam Tosilate on Oxygenation and Postoperative Cognitive Function in Elderly Patients Undergoing Thoracoscopic Lobectomy (NCT07086911) | Jinqiao Qian | 2025-08-01 |
| Exploratory Study of the Effects of Peptide PMS-001 on Long-Delay Recall in Patients With Moderate to Severe Dementia (NCT06946511) | Ruijin Hospital | 2025-08-01 |
| WGc-0201 Plus Tislelizumab in HCC With High Risk of Recurrence and Metastasis After Radical Therapy (NCT07077369) | West China Hospital | 2025-08-01 |